Sex-specific impact of the COVID-19 outbreak on the incidence of metabolic syndrome: a ...

1. Patel V, Fancourt D, Furukawa TA, Kola L. Reimagining the journey to recovery: the COVID-19 pandemic and global mental health. PLoS Med 2023;20:e1004224.
crossref pmid pmc
2. Borges do Nascimento IJ, O’Mathúna DP, von Groote TC, et al. Coronavirus disease (COVID-19) pandemic: an overview of systematic reviews. BMC Infect Dis 2021;21:525.
pmid pmc
3. Mamudu HM, Adzrago D, Odame EO, et al. The prevalence of metabolic conditions before and during the COVID-19 pandemic and its association with health and sociodemographic factors. PLoS One 2023;18:e0279442.
crossref pmid pmc
4. Saklayen MG. The global epidemic of the metabolic syndrome. Curr Hypertens Rep 2018;20:12.
crossref pmid pmc pdf
5. Kim A, Kim EY, Kim J. Impact of the COVID-19 Pandemic on obesity, metabolic parameters and clinical values in the South Korean adult population. J Clin Med 2024;13:2814.
crossref pmid pmc
6. Sohn M, Koo BK, Yoon HI, et al. Impact of COVID-19 and associated preventive measures on cardiometabolic risk factors in South Korea. J Obes Metab Syndr 2021;30:248–260.
crossref pmid pmc
7. Lee KS, Eom JK. Systematic literature review on impacts of COVID-19 pandemic and corresponding measures on mobility. Transportation (Amst) 2024;51:1907–1961.
crossref pmid pmc pdf
8. Barkhordarian M, Behbood A, Ranjbar M, Rahimian Z, Prasad A. Overview of the cardio-metabolic impact of the COVID-19 pandemic. Endocrine 2023;80:477–490.
crossref pmid pmc pdf
9. Strack C, Behrens G, Sag S, et al. Gender differences in cardiometabolic health and disease in a cross-sectional observational obesity study. Biol Sex Differ 2022;13:8.
crossref pmid pmc pdf
10. Ye Y, Zhou Q, Dai W, et al. Gender differences in metabolic syndrome and its components in southern china using a healthy lifestyle index: a cross-sectional study. BMC Public Health 2023;23:686.
crossref pmid pmc pdf
11. Ying X, Yang S, Li S, et al. Prevalences of metabolic syndrome and its sex-specific association with socioeconomic status in rural China: a cross-sectional study. BMC Public Health 2021;21:2033.
crossref pmid pmc pdf
12. Kudo N, Nishide R, Mizutani M, Ogawa S, Tanimura S. Association between the type of physical activity and metabolic syndrome in middle-aged and older adult residents of a semi-mountainous area in Japan. Environ Health Prev Med 2021;26:46.
crossref pmid pmc pdf
13. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120:1640–1645.
crossref pmid
14. Lee SY, Park HS, Kim DJ, et al. Appropriate waist circumference cutoff points for central obesity in Korean adults. Diabetes Res Clin Pract 2007;75:72–80.
crossref pmid
15. Sanchis-Gomar F, Lavie CJ, Mehra MR, et al. Obesity and outcomes in COVID-19: when an epidemic and pandemic collide. Mayo Clin Proc 2020;95:1445–1453.
crossref pmid pmc
16. Verdecchia P, Cavallini C, Spanevello A, Angeli F. The pivotal link between ACE2 deficiency and SARS-CoV-2 infection. Eur J Intern Med 2020;76:14–20.
crossref pmid pmc
17. Muniyappa R, Gubbi S. COVID-19 pandemic, coronaviruses, and diabetes mellitus. Am J Physiol Endocrinol Metab 2020;318:E736–E741.
crossref pmid pmc
18. Korakas E, Ikonomidis I, Kousathana F, et al. Obesity and COVID-19: immune and metabolic derangement as a possible link to adverse clinical outcomes. Am J Physiol Endocrinol Metab 2020;319:E105–E109.
crossref pmid pmc
19. Cai Q, Chen F, Wang T, et al. Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Diabetes Care 2020;43:1392–1398.
pmid
20. Docherty AB, Harrison EM, Green CA, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 2020;369:m1985.
crossref pmid pmc
21. Liang X, Or B, Tsoi MF, Cheung CL, Cheung BMY. Prevalence of metabolic syndrome in the United States National Health and Nutrition Examination Survey 2011–18. Postgrad Med J 2023;99:985–992.
crossref pmid pdf
22. Jeong SM, Jung JH, Yang YS, et al. 2023 Obesity Fact Sheet: prevalence of obesity and abdominal obesity in adults, adolescents, and children in Korea from 2012 to 2021. J Obes Metab Syndr 2024;33:27–35.
crossref pmid pmc
23. Huh JH, Kang DR, Kim JY, Koh KK. Metabolic Syndrome Fact Sheet 2021: executive report. Cardiometab Syndr J 2021;1:125–134.
crossref pdf
24. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among u.s. Adults. Diabetes Care 2004;27:2444–2449.
crossref pmid pdf
25. Pedersen JM, Lund R, Andersen I, Clark AJ, Prescott E, Rod NH. Psychosocial risk factors for the metabolic syndrome: a prospective cohort study. Int J Cardiol 2016;215:41–46.
crossref pmid
26. Jung H, Sung YA, Hong YS, Song DK, Hong SH, Lee H. Relationship between age at menarche and metabolic diseases in Korean postmenopausal women: The Korea National Health and Nutrition Examination Survey 2016–2018. PLoS One 2023;18:e0280929.
crossref pmid pmc
27. Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the United States, 1988–2012. JAMA 2015;314:1021–1029.
crossref pmid
28. Wang Q, Zhang X, Fang L, Guan Q, Gao L, Li Q. Physical activity patterns and risk of type 2 diabetes and metabolic syndrome in middle-aged and elderly Northern Chinese adults. J Diabetes Res 2018;2018:7198274.
crossref pmid pmc pdf
29. Park EJ, Shin HJ, Kim SS, et al. The effect of alcohol drinking on metabolic syndrome and obesity in Koreans: big data analysis. Int J Environ Res Public Health 2022;19:4949.
crossref pmid pmc

Comments (0)

No login
gif